Horsens fertility Clinic, Region Hospital Horsens
Horsens, 8700, Denmark
NCT Number: NCT03880994
This is a prospective observational study, that investigates men diagnosed with testicular cancer before and after treatment.
The patients are included at their visit at the Fertility clinic in Horsens, where they deposit semen for cryopreservation prior to surgery and potential systemic treatment. Here the patients, who want to participate will perform a cognitive test and afterwards complete a questioner (T1). After 9 month the patients will be invited to perform the cognitive test and complete the questionnaire again (T2).
Looking for future studies?
Notify Me18 year–45 year
Male
Observational
Horsens, 8700, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 9 months. The patients complete the cognitive test at baseline (T1) and again after 9 months (T2).
The cognitive test is performed on an iPad using the validated Cambridge Neuropsychological Test Automated Battery (CANTAB) Connect Research software. The cognitive domains assessed are sensorimotor function and comprehension, processing and psychomotor speed, sustained attention, visual episodic memory, working memory and strategy, visual working memory and planning, each at T1 and T2. Comparison of test results from T1 and T2 will assess if there is a change in the cognitive performance.
Time frame: 9 months. The patients complete the questionnaire at baseline (T1) and again after 9 months (T2).
Assessed by The Patients Assessment of Own Functioning Inventory (PAOFI)
Time frame: 9 months. The patients complete the questionnaire at baseline (T1) and again after 9 months (T2).
Assessed by the EORTC Sexual Health Questionnaire (EORTC SHQ-C22)
Time frame: 9 months. The patients complete the questionnaire at baseline (T1) and again after 9 months (T2).
Assessed by The International Index of Erectile Function (IIEF-5)
Time frame: 9 months. The patients complete the questionnaire at baseline (T1) and again after 9 months (T2).
Assessed by the Hospital Anxiety and Depression Scale (HADS). The HADS is a 14-item scale with 2 subscales measuring severity of anxiety (HADS-A) and depression (HADS-D) symptoms. Each subscale has 7 items and each item is scored from 0-3. Thus, the total score for each subscale range from 0-21, with 0 indicating no symptoms and 21 severe symptoms.
Time frame: 9 months. The patients complete the questionnaire at baseline (T1) and again after 9 months (T2).
Assessed by the FACIT_Fatigue Questionnaire. The questionnaire consists of 13-items each scored from 0-4. The scores are summarized, and the total score range from 0-52 with higher score denoting less fatigue.
Time frame: 9 months. The patients complete the questionnaire at baseline (T1) and again after 9 months (T2).
Assessed by the Pittsburgh Sleep Quality Index (PSQI)
Time frame: 9 months. The patients complete the questionnaire at baseline (T1) and again after 9 months (T2).
The quality of life is assessed by a subscale from the WHO Quality of Life (WHOQOL)-BREF questionnaire. The subscale has 2 questions each scored from 1-5. Thus, the total score for this subscale range from 2-10 with higher scores denoting higher quality of life.
Time frame: 9 months. The patients complete the questionnaire at baseline (T1) and again after 9 months (T2).
The wellbeing is assessed by the WHO (Five) Well-being scale (WHO-5), that has 5 questions each scored from 0-5. The raw score ranges from 0-25 and is multiplied by 4 to give the final score that ranges from 0-100, with higher scores denoting higher wellbeing.
Time frame: The Patients complete the questions at baseline (T1).
The patient answers 5 questions regarding fertility related concerns, investigating if he has concerns about being able to become a father with or without fertility assistance. Also, the patient answers 4 questions regarding the information given by healthcare professionals, to assess if he finds, that he has been given enough information regarding semen deposit and possible later fertility assistance.
None of these 9 questions are validated.
University of Aarhus
Other
Mental Health of Men Before and After Testicular Cancer Treatment. Danish: "Mænds Mentale Sundhed før og Efter Behandling af testikulær kræft"
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07568444
Adenocarcinoma, Bladder Cancer
Los Angeles, California, United States
View Trial DetailsNCT03426865
Endocrine Gland Neoplasms, Endocrine System Diseases
Dallas, Texas, United States
View Trial DetailsNCT04028479
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Idaho Falls, Idaho, United States
View Trial DetailsNCT02429466
Endocrine Gland Neoplasms, Endocrine System Diseases
Indianapolis, Indiana, United States
View Trial Details